Edition:
India

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

15.36HKD
15 Dec 2017
Change (% chg)

HK$-0.32 (-2.04%)
Prev Close
HK$15.68
Open
HK$15.60
Day's High
HK$15.66
Day's Low
HK$15.16
Volume
20,360,452
Avg. Vol
17,139,712
52-wk High
HK$16.70
52-wk Low
HK$7.96

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical Group announces change of shareholdings of substantial shareholder
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>:‍Massive Giant Group transferred approximately 6.78% of total issued shares to Common Success International​.  Full Article

CSPC Pharmaceutical Group posts 9-month profit attributable of HK$‍2.04​ bln
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>:9-month profit attributable HK$‍2.04​ billion versus HK$1.57 billion.9-month ‍ total revenue HK$11.21 billion versus HK$9.25 billion.  Full Article

CSPC Pharmaceutical Group ‍to issue 189 mln placing shares at HK$12.44 per share​
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>-:‍shall issue 189 million placing shares at placing price of hk$12.44 per share​.application will be made to stock exchange for resumption of trading with effect from 9:00 a.m. On 13 oct 2017​.  Full Article

CSPC Pharmaceutical Group's unit buys 1.31 PCT stake in CSPC Innovation Pharmaceutical
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>:Unit announces ‍acquisition of 1.31 percent stake in CSPC Innovation Pharmaceutical Co for RMB 9.4 million.Unit signs agreement with vendor Zhongchengxin​.  Full Article

CSPC Pharmaceutical appoints vice-chairman and rotating CEO
Thursday, 25 May 2017 

May 25 (Reuters) - CSPC Pharmaceutical Group Limited <1093.HK>:Pan Waidong has been appointed as vice-chairman and rotating chief executive officer of company.  Full Article

CSPC Pharmaceutical says unit entered agreement with Casper Pharma
Monday, 12 Dec 2016 

Cspc Pharmaceutical Group Ltd <1093.HK> : Unit entered into an agreement with Casper Pharma in relation to the product licensing of complex generic oncology drug .Pursuant to agreement, CSPC Zhongqi agrees to grant right to casper to perform the necessary clinical studies.  Full Article

CSPC Pharmaceutical says HY revenue of hk$6.15 bln vs hk$5.73 bln<1093.HK>
Tuesday, 23 Aug 2016 

CSPC Pharmaceutical Group Ltd <1093.HK>: 2016 interim results announcement <1093.HK> . HY profit attributable to shareholders hk$1.03 billion versus hk$822 million . HY revenue of hk$6.15 billion versus hk$5.73 billion . Directors do not declare the payment of an interim dividend for the six months ended 30 June 2016 . Directors do not declare the payment of an interim dividend .  Full Article

CSPC Pharmaceutical Group announces entery into lease agreements<1093.HK>
Monday, 27 Jun 2016 

CSPC Pharmaceutical Group Ltd <1093.HK>: Continuing connected transactions - lease agreements <1093.HK> . Says CSPC Zhongnuo (as tenant) and CHL (as landlord) entered into two new lease agreements . Lease agreements in respect of premises 1, 2 and 3 for a term of three years commenced on 25 June 2016 . Says the board confirms rental payable, being RMB18.4 million per annum in aggregate .  Full Article

CSPC Pharmaceutical says unit CSPC Shengxue Glucose Co enters into Steam Supply Agreement<1093.HK>
Monday, 13 Jun 2016 

CSPC Pharmaceutical Group Ltd <1093.HK>: 1) completion of the acquisition of 93.18% equity interest in CSPC shengxue glucose co., ltd. and (2) continuing connected transactions <1093.HK> . Says unit entered into the steam supply agreement with Hebei hongyuan . Agreement in relation to the purchase of steam by shengxue from Hebei hongyuan commencing from 13 June 2016 to 12 June 2019 .  Full Article

CSPC Pharmaceutical reports qtrly net profit of HK$505.6 mln vs HK$400.3 mln<1093.HK>
Wednesday, 18 May 2016 

CSPC Pharmaceutical Group Ltd <1093.HK>: Unaudited results for the three months ended 31 March 2016 . Qtrly revenue HK$2.99 billion versus HK$2.78 billion . Qtrly net profit HK$505.6 million versus HK$400.3 million a year ago . Board of directors does not declare payment of an interim dividend for three months ended 31 March 2016 .  Full Article

BRIEF-CSPC Pharmaceutical Group Appoints ‍Li Chunlei As Executive Director ​

* ‍LI CHUNLEI WAS APPOINTED AS AN EXECUTIVE DIRECTOR OF COMPANY WITH EFFECT FROM 12 DECEMBER 2017.​